Despite early success, however, Novo Nordisk has fallen behind in the GLP-1RA race, overtaken by Eli Lilly and its GLP-1RA ...

Wegovy-maker Novo Nordisk ousted CEO Lars Fruergaard Jorgensen on Friday over concerns the company is losing its first-mover ...

The Danish drugmaker, which makes Ozempic and Wegovy, has seen its stock tumble as competition in the weight-loss drug market ...

24/7 Wall St. aims to present some farther-looking insights based on Novo Nordisk’s own numbers ... the UK’s Association of British Pharmacy Industry over ethics violations tantamount to ...

That’s a bit harsh given Denmark’s strong growth compared with neighboring countries over the past few years has been largely ...

an online weight loss company called Noom has begun selling smaller doses of compounded versions of Novo Nordisk's Wegovy GLP-1 drug. This development comes as the compounding pharmacy industry ...

Novo Nordisk — the Danish drug manufacturer that makes Wegovy — today announced that Lars Fruergaard Jørgensen, its CEO, is stepping down from the CEO post. The company announced that it made ...

Novo Nordisk CEO steps down after pressure from shareholders. Former CEO to join board as observer. Company remains ...

Novo Nordisk A/S is replacing Chief Executive Officer ... for its Wegovy obesity shots that transformed the weight-loss industry and made the Danish company the star of corporate Europe.